2009 Fall Summary of Joint Committee Meeting.doc
  
2009 Fall Summary of Joint Committee Meeting
2009.Spring.Committee.Report.A.doc
  
2009.Spring.Committee.Report.A
2009.Spring.Committee.Report.doc
  
2009.Spring.Committee.Report
2010 Aug-Response to USPTO- Biotech-Cmte-Restrict-Req-Cmnts.pdf
  
2010-Aug-Response to USPTO- Biotech-Cmte-Restrict-Req-Cmnts
2010 Oct Report Antibody guidelines.DOC
  
2010 Oct Report on Draft EMA Guidelines on Biosimilars and mAbs
2010 Spring_Mtg.Biotech.pdf
  
2010 Spring_Mtg.Biotech
2010 Summer Biotech-Survey-Results.pdf
  
2010 Summer Biotech-Survey-Results
2011.Annual.Committee.Meeting.Notes.doc
  
2011 Annual Committee Meeting Notes
2011BiotechSurvey.RESULTS.doc
  
2011 Survey Results
2011Oct Biotechnology Committee Report.doc
  
2011Fall Biotech Committee Report to Board
2012.Annual.Antibody.Patenting.Issues.US.EP.docx
  
Report of Joint CLE Session on Antibody Patenting in the US and EP from 2012 Annual Meeting
2012.Annual.CLE.Session.Novel.Financing.Report.doc
  
Kristin Connarn's Summary of the CLE Session on Novel Financing
20151202  Biotech WorkPlan.docx
  
2015 Biotech Committee Report
20160227  Biotech WorkPlan.docx
  
2016 Biotech Committee Report
Biotechnology Committee Report October 2012.DOCX
  
Committee Report May 2012 (00015434).DOCX